Home/Platforms/Strand Therapeutics

Strand Therapeutics

by Strand Therapeutics

A Flagship Pioneering company developing programmable mRNA therapeutics that incorporate genetic logic circuits. Strand's platform encodes Boolean logic (AND, OR, NOT gates) directly into mRNA molecules, enabling cell-type-specific expression and smart therapeutics that activate only in target cells — a major advance over conventional mRNA approaches.

Type
mrna-programming
Chassis
N/A (mRNA circuits)
Vertical
therapeutics
Stage
clinical
Funding
$200M+
← Back to Platform Database